Fabrication of a Lateral Flow Assay for Rapid In-Field Detection of COVID-19 Antibodies Using Additive Manufacturing Printing Technologies

Research output: Contribution to journalArticlepeer-review

8 Scopus citations

Abstract

The development of lateral flow immunoassay (LFIA) using three-dimensional (3D) printing and bioprinting technologies can enhance and accelerate the optimization process of the fabrication. Therefore, the main goal of this study is to investigate methods to speed up the developing process of a LFIA as a tool for community screening. To achieve this goal, an in-house developed robotic arm and microfluidic pumps were used to print the proteins during the development of the test. 3D printing technologies were used to design and print the housing unit for the testing strip. The proposed design was made by taking into consideration the environmental impact of this disposable medical device.
Original languageEnglish (US)
Pages (from-to)1-9
Number of pages9
JournalInternational Journal of Bioprinting
Volume7
Issue number4
DOIs
StatePublished - Aug 23 2021

Bibliographical note

KAUST Repository Item: Exported on 2023-08-05
Acknowledgements: This work was financially supported by King Abdullah University of Science and Technology (KAUST) and by King Abdulaziz City for Science and Technology (KACST) with a funded grant (4419-KACST COVID -19).

Fingerprint

Dive into the research topics of 'Fabrication of a Lateral Flow Assay for Rapid In-Field Detection of COVID-19 Antibodies Using Additive Manufacturing Printing Technologies'. Together they form a unique fingerprint.

Cite this